ADCIRCA (Avera McKennan Hospital)
Welcome to the PulseAid listing for the ADCIRCA drug offered from Avera McKennan Hospital. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | Tadalafil |
| SUBSTANCE NAME: | TADALAFIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-10-28 |
| END MARKETING DATE: | 0000-00-00 |
ADCIRCA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ADCIRCA from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2015-10-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0472_8345c166-96c1-40fe-a121-419e5a3613cf |
| PRODUCT NDC: | 69189-0472 |
| APPLICATION NUMBER: | NDA022332 |
Other TADALAFIL Pharmaceutical Manufacturers / Labelers:
